Reed Elizabeth Einsider trades
In SEC Form 4 filings, Reed Elizabeth E is listed as Chief Legal Officer and GC of Travere Therapeutics, Inc. (TVTX). In the last 90 days, Reed Elizabeth E sold $2.34M of Travere Therapeutics, Inc. (TVTX) on the open market and bought none. All 4 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Chief Legal Officer and GC | 6 | Sep 17 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-17
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 37,500 | $15.46 | $579,750 | 142,889 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 21,926 | $62.03 | Sale −$1,359,971 | 120,963 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 13,874 | $62.63 | Sale −$868,965 | 107,089 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 1,400 | $63.69 | Sale −$89,166 | 105,689 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 300 | $65.31 | Sale −$19,593 | 105,389 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 37,500 | $15.46 | $579,750 | not reported | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.